Caliper, AntiCancer cross-license several optical imaging patents

February 29, 2008, Hopkinton, MA and San Diego, CA--Caliper Life Sciences and AntiCancer have entered into an agreement to establish a cross-licensing relationship and end all outstanding patent litigation between the two companies related to in vivo fluorescence imaging for pharmaceutical and biotech applications.

February 29, 2008, Hopkinton, MA and San Diego, CA--Caliper Life Sciences and AntiCancer have entered into an agreement to establish a cross-licensing relationship and end all outstanding patent litigation between the two companies related to in vivo fluorescence imaging for pharmaceutical and biotech applications.

More in Home